ConductScience.org, home

Paper21998583

Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.

Smith DS and 7 others. PLoS Pathog, 2011. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. Papers, record 21998583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21998583

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
PubMed
Journal
PLoS Pathog
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2025-05-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith DSDiana S
2Guo KKejun
3Barrett BSBradley S
4Heilman KJKarl J
5Evans LHLeonard H
6Hasenkrug KJKim J
7Greene WCWarner C
8Santiago MLMario L

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
Antibody FormationMajor topic
Cytidine DeaminaseMajor topic
Friend murine leukemia virusMajor topic
VirionMajor topic
Animals
Antiviral Agents
Mice
Mice, Inbred BALB C
Mice, Knockout
Phenotype
Plasma
Promoter Regions, Genetic
RNA, Viral
Reverse Transcription
Sequence Analysis, RNA
Viral Load

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 AI027763NIAID NIH HHSUnited StatesP30AI027763PubMed and NIHNIH RePORTER
R01 AI090795NIAID NIH HHSUnited StatesR01AI090795PubMed and NIHNIH RePORTER
R56 AI084123NIAID NIH HHSUnited StatesR56AI084123PubMed and NIHNIH RePORTER
Intramural NIH HHSUnited StatesPubMedPubMed
ZIAAI000753NIHNIH RePORTER
ZIAAI001103NIHNIH RePORTER

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,670,036HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.J Exp Med1998https://conductscience.org/library/papers/9670036PubMed
220,980,520Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.J Virol2011https://conductscience.org/library/papers/20980520PubMed
315,297,622Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15297622PubMed
412,859,895Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.Cell2003https://conductscience.org/library/papers/12859895PubMed
514,528,301HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.Nat Med2003https://conductscience.org/library/papers/14528301PubMed
616,103,203APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.J Virol2005https://conductscience.org/library/papers/16103203PubMed
715,098,018Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.Nat Struct Mol Biol2004https://conductscience.org/library/papers/15098018PubMed
820,457,926Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20457926PubMed
912,167,863Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.Nature2002https://conductscience.org/library/papers/12167863PubMed
1015,650,227G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.J Virol2005https://conductscience.org/library/papers/15650227PubMed
1114,527,406HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.Mol Cell2003https://conductscience.org/library/papers/14527406PubMed
1218,598,197Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.J Infect Dis2008https://conductscience.org/library/papers/18598197PubMed
1319,153,233Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.J Virol2009https://conductscience.org/library/papers/19153233PubMed
1420,375,169Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.J Virol2010https://conductscience.org/library/papers/20375169PubMed
1519,027,134Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.Virology2009https://conductscience.org/library/papers/19027134PubMed
1614,528,300The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.Nat Med2003https://conductscience.org/library/papers/14528300PubMed
176,833,759Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.J Immunol1983https://conductscience.org/library/papers/6833759PubMed
187,518,532Characterization of epitopes defining two major subclasses of polytropic murine leukemia viruses (MuLVs) which are differentially expressed in mice infected with different ecotropic MuLVs.J Virol1994https://conductscience.org/library/papers/7518532PubMed
1920,566,830Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.J Immunol2010https://conductscience.org/library/papers/20566830PubMed
2012,163,607Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.J Virol2002https://conductscience.org/library/papers/12163607PubMed

See all 68 references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
38,856,651Reduced vacuolar ATPase protects mice from Friend virus infection - an unintended but instructive effect in Hif-2afl mice.J Cell Sci2024https://conductscience.org/library/papers/38856651PubMed
34,893,529SAMHD1 Promotes the Antiretroviral Adaptive Immune Response in Mice Exposed to Lipopolysaccharide.J Immunol2022https://conductscience.org/library/papers/34893529PubMed
33,121,095Mouse APOBEC3 Restriction of Retroviruses.Viruses2020https://conductscience.org/library/papers/33121095PubMed
32,051,266Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.J Virol2020https://conductscience.org/library/papers/32051266PubMed
31,087,035Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.FEMS Microbiol Rev2019https://conductscience.org/library/papers/31087035PubMed
30,782,653Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral Persistence.mBio2019https://conductscience.org/library/papers/30782653PubMed
30,574,147Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.Front Immunol2018https://conductscience.org/library/papers/30574147PubMed
28,415,995Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.Retrovirology2017https://conductscience.org/library/papers/28415995PubMed
27,880,772T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses.PLoS One2016https://conductscience.org/library/papers/27880772PubMed
27,477,283Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1.Cell Rep2016https://conductscience.org/library/papers/27477283PubMed
26,957,198Tetherin/BST-2: Restriction Factor or Immunomodulator?Curr HIV Res2016https://conductscience.org/library/papers/26957198PubMed
26,846,717Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.Sci Rep2016https://conductscience.org/library/papers/26846717PubMed
26,529,416Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.PLoS Pathog2015https://conductscience.org/library/papers/26529416PubMed
25,994,147Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.Immunogenetics2015https://conductscience.org/library/papers/25994147PubMed
25,818,029APOBECs and virus restriction.Virology2015https://conductscience.org/library/papers/25818029PubMed
25,589,647Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.J Virol2015https://conductscience.org/library/papers/25589647PubMed
25,539,593Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.Retrovirology2014https://conductscience.org/library/papers/25539593PubMed
25,501,566APOBEC3 enzymes restrict marginal zone B cells.Eur J Immunol2015https://conductscience.org/library/papers/25501566PubMed
25,303,118Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.Virology2014https://conductscience.org/library/papers/25303118PubMed
24,872,193Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.J Immunol2014https://conductscience.org/library/papers/24872193PubMed

See all 31 cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21998583

GET https://conductscience.org/api/papers/v1/21998583/references?page=2